FDA Adverse Event Malfunction Summary report: N

ELECSYS TSH ASSAY

MDR report key: 6175351 · Received December 15, 2016

Report

Report Number
1823260-2016-01963
Event Type
Malfunction
Date Received
December 15, 2016
Date of Event
November 28, 2016
Report Date
January 17, 2017
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JLW
PMA / PMN Number
K961491
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE EVENT OCCURRED IN (B)(6).

Additional Manufacturer Narrative · 1

THE TWO PATIENT SAMPLES WERE RETURNED TO THE MANUFACTURER FOR TESTING. THE INVESTIGATION REPRODUCED THE CUSTOMER'S RESULTS. INTERFERENCE TESTING WAS PERFORMED. NO INTERFERENCES WERE FOUND. NO PRODUCT PROBLEM WAS FOUND.

Additional Manufacturer Narrative · 1

CALIBRATION SIGNALS WERE OK. CONTROL VALUES WERE WITHIN SPECIFICATIONS. A GENERAL REAGENT ISSUE CAN MOST LIKELY BE EXCLUDED. FACTORS SUCH AS STRESS, CHANGES IN PHYSICAL ACTIVITIES AND CIRCADIAN VARIATIONS CAN CAUSE VARIATIONS IN TSH VALUES TAKEN FROM SAMPLES FROM THE SAME PATIENT IN A SHORT PERIOD OF TIME.

Description of Event or Problem · 1

THE CUSTOMER COMPLAINED OF QUESTIONABLE RESULTS FOR TWO SAMPLES FROM THE SAME PATIENT TESTED WITH THE ELECSYS TSH ASSAY ON A COBAS 6000 E 601 MODULE. THE SERIAL NUMBER OF THE ANALYZER WAS NOT PROVIDED. THE FIRST SAMPLE WAS TESTED (B)(6) 2016 WITH A TSH OF 8.06 MU/L; THE REPEAT RESULT WAS 8.06 MU/L. THE SECOND SAMPLE WAS TESTED (B)(6) 2016 WITH A TSH OF 3.04 MU/L; THE REPEAT RESULT WAS 3.04 MU/L. TO THE BEST OF THE CUSTOMER'S KNOWLEDGE, THE PATIENT RECEIVED NO TREATMENT BETWEEN THE TWO SAMPLES. THE CLINICIAN DID NOT AGREE WITH THE DIFFERENCE IN THE RESULTS. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. PATIENT SAMPLES WERE SENT TO THE MANUFACTURER FOR TESTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
829135 ELECSYS TSH ASSAY RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE JLW ROCHE DIAGNOSTICS NA 185522

Patients

Seq Age Sex Outcome Treatment
1